Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APG-157 in Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT07667296Phase 3Not yet recruiting
- Sponsor
- Aveta Biomics
- Start
- Jul 2026
- Primary completion
- Dec 2031
01
Overview
A Phase 3 trial of APG-157 in head and neck squamous cell carcinoma (HNSCC), sponsored by Aveta Biomics. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
APG-157
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT07667296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07667296.